应用 | 建议稀释比 | 已发表文章 |
---|---|---|
酶联免疫吸附实验 (ELISA) |
1-10 µg/mL | - |
产品规格 | |
---|---|
种属反应 |
Bacteria |
宿主/亚型 |
Mouse / IgG2b |
分类 |
Monoclonal |
类型 |
Antibody |
克隆号 |
GC12-351.4 |
抗原 |
UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III. |
偶联物 |
Unconjugated |
形式 |
Liquid |
浓度 |
2.5 mg/mL |
纯化类型 |
purified |
保存液 |
PBS, pH 7.4 |
内含物 |
no preservative |
保存条件 |
-20° C, Avoid Freeze/Thaw Cycles |
RRID |
AB_1077100 |
MA1-10717 detects Neisseria gonorrhoeae.
MA1-10717 has been successfully used in ELISA applications.
The MA1-10717 immunogen is UV-inactivated Neisseria gonorrhoeae cells W-I, W-II, W-III.
Although pathogenic bacteria constitute only a small portion of bacterial species, infectious diseases caused by pathogenic bacteria affect millions of people worldwide. Diarrheal diseases, many of which are bacterial, are the second leading cause of death worldwide, claiming an estimated 5 million people annually. Furthermore, an estimated 3 million people die of tuberculosis annually, 500,000 people die of pertussis, and 25,000 die of typhoid. The ability of bacteria to utilize various food sources is a major factor behind their pervasiveness. Their vast numbers lead to rapid evolutionary changes resulting in emerging diseases as well as antibiotic-resistant strains of well known diseases. Examples of these are multi-drug resistant tuberculosis and methicillin-resistant Staphylococcus aureus. Research into the detection and treatment of these infectious disease agents will continue to expand in an effort to alleviate the effects of these diseases.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Gonococci; N. gonorrhoeae